Thirty-nine percent of patients were able to either “completely discontinue [their use of] insomnia medications or reduce their use from nightly administration to as-needed administration.”
Day: May 12, 2022
Since 1992, every Thursday and when breaking news warrants, NORML/NORML Foundation have been issuing weekly press releases for marijuana law supporters and the media. Subscribe to NORML News.
NORML’s News Releases archives goes back to 1996 and serves as a valuable tool to alert citizens about marijuana-related news and legislation as well as a research tool for reviewing a chronology-of-sorts of marijuana law reform.
Investigators concluded, “[P]atients who seek treatment with medical cannabis for anxiety and depression can experience clinically significant improvements.”
Authors reported, “[P]eople with PD report that cannabis subjectively improves some PD‐related symptoms, with higher THC products conferring more frequent benefits than higher CBD products.”
The analysis found that nearly two-thirds of the products contained synthetically derived THC, despite many claiming to be ‘all natural.’